Sort   by:  
 Page size 
Only a minority of cancer patients benefit from immune checkpoint blockade therapy. Sophisticated cross-talk among different immune checkpoint pathways as well as interaction pattern of immune checkpoint molecules carried on circulating small extracellular vesicles (sEV) might contribute to the low ...
ORGANISM(S): Homo sapiens (Human) 
2024-06-22 | PXD050744 | Pride
Sort   by:  
 Page size